4.6 Article

Bi-modal system-on-chip platform for bilirubin monitoring by using photometric and temporal degradation approaches

期刊

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.bspc.2023.104848

关键词

Bilirubin; Biomarker; Photodegradation; Point-of-care; System-on-a chip

向作者/读者索取更多资源

Hyperbilirubinemia in infants and cirrhosis in adults are major global diseases, especially in areas with limited healthcare resources. Existing techniques for measuring bilirubin suffer from complexity and size limitations. This study presents a miniature system-on-chip platform for bilirubin measurement, achieving accurate results and laying the foundation for point-of-care monitoring of hyperbilirubinemia and cirrhosis.
Hyperbilirubinemia in infants and cirrhosis in adults remain major global causes of sickness and death, predominantly for people living in areas with poor or limited healthcare resources. Clinically, the two conditions require measuring levels of bilirubin in blood for diagnostic and prognostic purposes. While the existing techniques provide the most comprehensive pathology-lab results, they suffer from complexity and size requirements, and measurements are impractical for point-of-Care (PoC) testing. Furthermore, the existing transcutaneous devices (for neonates) are pricey, preventing the possibility of dissemination for home health care applications. This study uses an integrated and all-inclusive miniature (3.5 x 7.0 mm) system-on-chip platform (MAX86916) to measure bilirubin concentration. On MAX86916 embeds two optical sources (blue LED and green LED) which are utilized for dual-wavelength (DWL) measurement. Furthermore, a new photodegradation kinetics approach was incorporated with DWL approach to enhance the overall system reliability and accuracy. Bilirubin concentration was extracted by monitoring the optical transmission and the photodegradation responses. Measurements were carried out on porcine blood, the best existing surrogate for human blood, and the concentration of bilirubin was maintained within the range of pathophysiological levels (1 mg/dL to 50 mg/dL). The measurement could require a volume of less than 10 mu L of a blood sample. Our findings show a good system accuracy of similar to +/- 10 % and lay the groundwork for PoC bilirubin monitoring, primarily for hyperbilirubinemia and cirrhosis out of clinics and hospitals.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据